Home » Clinical Trials » Leukemia » NCT05909527
NCT05909527

A Single-arm, Open-label, Single-center Clinical Study: Safety and Efficacy of Anti-CD7 CAR-T in the Treatment of Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma

Study Summary

This study is a single arm, non blind, randomized, single center study aimed at evaluating the safety, pharmacokinetic characteristics, and preliminary efficacy of CD7 CAR-T cell injection in r/r T-ALL/LBL subjects.

Want to learn more about this trial?

Request More Info

Interventions

CD7 CAR-TBIOLOGICAL
A single infusion of autologous CD7 CAR-T cells administered intravenously

Study Locations

FacilityCityStateCountry
Hebei Yanda HospitalLangfangHebeiChina

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026